Understanding OUR Cytokine-Based Immunotherapy Candidates Our Motivation extends to advancing a robust portfolio of programs targeted at growing the horizons of cytokine-based immunotherapy, specifically for cancers where cure solutions remain limited. Utilize the links below to learn additional about our portfolio of cytokine-based immunotherapy candidates. Take a look at https://financefeeds.com/more-capital-leaves-shiba-inu-shib-for-new-token-taking-on-shib-in-2025/